The recent discovery of miRNA and its wide applicability have sparked off a
lot of interest among researchers as well as commercial players. Owing to the
same, there are numerous clinical trials being organized all over the world in
order to assess the potential of miRNA in diverse fields such as Cancer, Asthma,
Heart disorders, Diabetes, Hepatitis etc. The report, “Global miRNA Market
Outlook to 2018” provides an in-depth analysis of the various aspects of miRNA
at the industry as well as the research front.

The market has been divided into three sections i.e., The Americas, Europe and
Asia Pacific. These regions have then been analyzed to draw patterns in terms of
research areas and applicability. A brief look at the market suggests that
cancer is the most researched topic and regions such as United States, United
Kingdom, France, Israel and China are the major players interested in evaluating
the role played by miRNA.

Most of the current research is focused on utilizing miRNA for diagnostic
purposes such as expression profiling, response evaluation and setting potential
biomarkers in diseases. Another application is in the field of therapeutics
where miRNA mimics and inhibitors are being applied to control gene translation
and consequently its expression.

After an exhaustive study of the industry, RNCOS has laid out the primary market
players. These players are working over a vast variety of products such as miRNA
extraction and purification kits, and miRNA mimics and inhibitors. There are
other players who are solely providing miRNA associated diagnostic services and
assessing their therapeutic potential.

Overall, even though the market is in its nascent stage at the moment, it is
expanding at an almost exponential rate. With new players entering the market,
increase in the number of collaborations and strong support from research
institutes, the miRNA market is bound to witness rampant diversification and
growth in the coming years.

The Botswana Pharmaceuticals & Healthcare Report features Business Monitor
International (BMI)'s forecasts for drugs and healthcare expenditure and imports
and exports, focusing on the growth outlook for the prescription, OTC, patented
drug...

$ 1,295.00

The Zambia Pharmaceuticals & Healthcare Report features BMI Research's
forecasts for drugs and healthcare expenditure and imports and exports, focusing
on the growth outlook for the prescription, OTC, patented drugs and generics
market segm...

$ 1,295.00

The Latvia Pharmaceuticals & Healthcare Report features Business Monitor
International (BMI)'s forecasts for drugs and healthcare expenditure and imports
and exports, focusing on the growth outlook for the prescription, OTC, patented
drugs ...

$ 1,295.00

The Brazil Pharmaceuticals & Healthcare Report features BMI Research's
forecasts for drugs and healthcare expenditure and imports and exports, focusing
on the growth outlook for the prescription, OTC, patented drugs and generics
market segm...

$ 1,295.00

The China Pharmaceuticals and Healthcare Report features BMI Research's
forecasts for drugs and healthcare expenditure and imports and exports, focusing
on the growth outlook for the prescription, OTC, patented drugs and generics
market segment...

$ 1,295.00

The Austria Pharmaceuticals & Healthcare Report features Business Monitor
International (BMI)'s forecasts for drugs and healthcare expenditure and imports
and exports, focusing on the growth outlook for the prescription, OTC, patented
drugs...